FdaApplication
ANDA 206029
Identifiers
- fda_app_no: ANDA206029
Properties
| Property | Value |
|---|---|
| applicant_name | LUPIN LTD |
| application_type | ANDA |
| approval_date | 2023-11-20 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PITAVASTATIN CALCIUM | PITAVASTATIN CALCIUM | EQ 1MG BASE | TABLET;ORAL |
| PITAVASTATIN CALCIUM | PITAVASTATIN CALCIUM | EQ 2MG BASE | TABLET;ORAL |
| PITAVASTATIN CALCIUM | PITAVASTATIN CALCIUM | EQ 4MG BASE | TABLET;ORAL |
3 products